Aysegul Erman
Overview
Explore the profile of Aysegul Erman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sahakyan Y, Erman A, Wong W, Greenaway C, Janjua N, Kwong J, et al.
Viruses
. 2024 Aug;
16(8).
PMID: 39205198
Background: The World Health Organization (WHO) has set hepatitis C (HCV) elimination targets for 2030. Understanding existing gaps in the "HCV care-cascade" is essential for meeting these targets. We aimed...
2.
Forouzannia F, Hamadeh A, Passos-Castilho A, Erman A, Yu A, Feng Z, et al.
Liver Int
. 2024 Mar;
44(6):1383-1395.
PMID: 38445848
Background: Patients with chronic hepatitis C (CHC) can be cured with the new highly effective interferon-free combination treatments (DAA) that were approved in 2014. However, CHC is a largely silent...
3.
Erman A, Sahakyan Y, Everett K, Greenaway C, Janjua N, Kwong J, et al.
Can J Gastroenterol Hepatol
. 2024 Mar;
2024:5573068.
PMID: 38434933
Background: Data on the economic burden of chronic hepatitis C (CHC) among immigrants are limited. Our objective was to estimate the CHC-attributable mortality and healthcare costs among immigrants in Ontario,...
4.
Anyiwe K, Erman A, Hassan M, Feld J, Pullenayegum E, Wong W, et al.
Lancet Infect Dis
. 2024 Jan;
24(6):e366-e385.
PMID: 38184004
Social determinants of health are important in designing effective interventions for hepatitis B virus (HBV) infection. This systematic review characterises equity-oriented, social determinants of health-focused HBV interventions, and describes their...
5.
Erman A, Everett K, Wong W, Forouzannia F, Greenaway C, Janjua N, et al.
Hepatol Commun
. 2023 Aug;
7(9).
PMID: 37556245
Background: HCV elimination requires a thorough understanding of the care cascade. A direct-acting antiviral (DAA)-era description of the care cascade has not been undertaken in Ontario, Canada's most populous jurisdiction....
6.
Sahakyan Y, Erman A, Bhojani N, Chughtai B, Zorn K, Sander B, et al.
Can Urol Assoc J
. 2022 Dec;
17(4):103-110.
PMID: 36486181
Introduction: Recently, minimally invasive surgical therapies (MIST s) have become an alternative to surgery or pharmacotherapy to manage benign prostatic hyperplasia (BPH ). This study evaluated the cost-utility of water...
7.
Medeiros M, Nai A, Erman A, Young E
Soc Sci Med
. 2022 Sep;
311:115358.
PMID: 36113210
The current study assesses the extent to which government leaders' personality traits are related to divergent policy responses during the pandemic. To do so, we use data from the Oxford...
8.
Cousineau S, Erman A, Liu L, Saeed S, Fradette L, Feld J, et al.
Can Liver J
. 2022 Aug;
3(1):3-14.
PMID: 35992037
Hepatitis C virus (HCV) affects approximately 250,000 Canadians. Although safe and effective (>95% cure rates) antiviral therapies have become available within the past 5 years, chronic HCV infection still remains...
9.
Chung K, Ho G, Erman A, Bielecki J, Forrest C, Sander B
Cleft Palate Craniofac J
. 2022 Jul;
60(12):1600-1608.
PMID: 35786020
Objective: The objective of this paper is to conduct a systematic review that summarizes the cost-effectiveness of cleft lip and/or palate (CL/P) care in low- and middle-income countries (LMICs) based...
10.
Sahakyan Y, Erman A, Bhojani N, Chughtai B, Zorn K, Sander B, et al.
Prostate Cancer Prostatic Dis
. 2022 Jun;
26(1):113-118.
PMID: 35689083
Background: Recently, minimally invasive therapies (MITs), such as water vapor thermal therapy (WVTT) and prostatic urethral lift (PUL) have become an alternative to surgery or pharmacotherapy to manage benign prostatic...